Showing results (1301-1310 of 3,033) with videos related to
Sort By:
Pageof 304
International Journal of Clinical Pharmacology and Therapeutics|March 6, 2013
Pharmacokinetics and efficacy of ropivacaine in Chinese patients following intra-articular administrationSaizhen Chen, Zhongyi Chen, Yinxiu Jin, et al.International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteersSirimas Kanjanawart, Dhanu Gaysonsiri, Katcharin Phunikom, et al.International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Bioequivalence assessment of a pregabalin capsule and oral solution in fasted healthy volunteers: a randomized, crossover studyHoward N Bockbrader, Christine W Alvey, Brian W Corrigan, et al.International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
In vivo evaluation of drug-drug interactions linked to UGT inhibition: the effect of probenecid on dalcetrapib pharmacokineticsPau Aceves Baldó, Judith Anzures-Cabrera, Darren BentleyInternational Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Changes to prothrombin international normalized ratio in patients receiving hemodialysisNoriaki Maruyama, Masanori Abe, Kazuyoshi Okada, et al.International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Factors that contribute to clopidogrel resistance in cardiovascular disease patients: environmental and genetic approachSayer I Al-Azzam, Karem H Alzoubi, Omar F Khabour, et al.International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjectsYanli Zhuang, Zhenhua Xu, Dick E de Vries, et al.International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Diagnosing malabsorption with systemic lipid profiling: pharmacokinetics of pentadecanoic acid and triheptadecanoic acid following oral administration in healthy subjects and subjects with cystic fibrosisVirginia A Stallings, John T Mondick, Joan I Schall, et al.International Journal of Clinical Pharmacology and Therapeutics|January 30, 2013
Risk factors for renal impairment in patients with solid tumors or multiple myeloma treated with zoledronic acidYou Jin Cha, Yu Jeung LeeInternational Journal of Clinical Pharmacology and Therapeutics|July 29, 2014
Impact of comorbidities on the treatment of atopic dermatitis in clinical practiceAlexandra Werner-Busse, Karel Kostev, Guido Heine, et al.Pageof 304